MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
Healthcare
$8.32 +5.08%
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
52W Low $6.07High $11.85
Volume 0.58M
Average 0.84M
Income Statement
Follow revenue through to earnings.
Revenue
$81.39M
FY 2025 · Annual
+144.6% YoYOperating Income
-$105.97M
FY 2025 · Annual
Net Income
-$114.20M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.7M | 15.92M | 14.02M | 33.28M | 81.39M |
| Cost of Revenue | 0 | 0 | 0 | 23.79M | 4.84M |
| Gross Profit | 37.7M | 15.92M | 14.02M | 9.49M | 76.55M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 28.5% | 94.0% |
| Research & Development | 66.69M | 85.73M | 103.79M | 119.48M | 129.62M |
| Selling, General & Admin | 43.77M | 46.55M | 47.29M | 54.22M | 52.9M |
| Operating Expenses | 110.46M | 132.28M | 151.08M | 173.7M | 182.52M |
| Depreciation & Amortization | 7.87M | 8.6M | 13.73M | 12.83M | 12.61M |
| EBITDA | (71.4M) | (116.07M) | (57.05M) | (121.69M) | (89.4M) |
| EBITDA Margin | -189.4% | -729.1% | -407.0% | -365.7% | -109.8% |
| Operating Income | (72.76M) | (116.36M) | (137.06M) | (164.21M) | (105.97M) |
| Operating Margin | -193.0% | -730.9% | -977.8% | -493.4% | -130.2% |
| Interest Income | 212K | 777K | 2.27M | 4.15M | 1.82M |
| Interest Expense | 288K | 4.95M | 13.25M | 13.27M | 12.2M |
| Other Income / Expenses | (6.8M) | (13.26M) | 53.03M | 16.42M | (8.23M) |
| Income Before Tax | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Pre-Tax Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Net Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| EPS (Basic) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| EPS (Diluted) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| 44.14M | 45.18M | 56.49M | 69.82M | 80.43M | |
| 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
MGTX Earnings Waterfall · TTM
NASDAQ:MGTX · Revenue to Net Income
Key Ratios
EPS$-1.48
Gross Margin-210.9%
Net Margin-7289.4%
P/E Ratio0.1
P/S Ratio1044.7
Analysis
$79.8M of revenue converted into -$120.5M of net income for the selected period. Gross margin is -210.9% and net margin is -7289.4%, showing how much revenue survives after costs and taxes. EPS is $-1.48, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| S-3ASR | S-3ASR filing | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 20, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 6, 2026 |
How much revenue does MGTX generate?
MeiraGTx Holdings plc (MGTX) reported $81.39M of revenue in fiscal 2025.
Is MGTX profitable?
MeiraGTx Holdings plc (MGTX) reported -$114.20M of net income, with a net margin of -140.3%.
Continue the stock analysis
Jump to another research area for this company.